Global private equity giants are retreating from African investment

The private equity firm Blackstone recently announced that it’s in the process of selling its Africa-focused subsidiary, Black Rhino Group, back to management. The decision reflects another lackluster year for African PE, which has seen little growth since the 2014 – 2015 fundraising boom that brought many firms into the market.

Background: In 2014, Blackstone acquired control of Black Rhino to invest billions into energy and infrastructure projects in Nigeria and Ethiopia, but it failed to close the large deals Blackstone was looking to finance. Blackstone’s departure comes after years of big American PE players leaving the market.

In late 2017, KKR disbanded its Africa team after making only one investment on the continent, in 2014, of $200 million in the world’s largest rose farm, Afriflora, that it has since sold.

While Carlyle closed a $698 million fund dedicated to Africa in 2014, one of its flagship investments, Nigeria’s Diamond Bank, has failed to perform, with shares falling over 90% since Carlyle invested $147 million.

Between the lines: The mismatch between the size of available deals in African markets and the target investment size of global asset managers such as Blackstone continues to be an issue.

Blackstone letting go of Black Rhino Group

In 2017, roughly 90% of Africa-focused Private Equity fund sizes were over $100 million, yet only about 15% of African private companies reported revenue over that number.

Moreover, the typical PE timeframe of a five-year holding period is often too short in African markets, where companies require more wholesale change, currency risk is a challenge, and exit opportunities are limited.

Click for more Africa business stories here

What to watch: As global PE giants leave the region, Africa-focused firms continue to grow. DPI, for example, is in the process of raising a third fund with an $800 million target. DPI and competitors like ECP, Helios, Actis, and Ethos tend to focus on smaller deals, often between $70 million and $100 million.

The bottom line: Funds that successfully tap opportunities in some of the world’s fastest-growing markets tend to share the traits of Africa specialization, patient capital, and tolerance and capacity for smaller assets. The big U.S. players appear uninterested in adapting to these realities in the near term.

Source: Aubrey Hruby — senior fellow in the Atlantic Council’s Africa Center.

About Oral Ofori

Check Also

Brain tumor

Brain Tumor: Some of the symptoms and signs to look out for

The symptoms of a brain tumor vary according to the size, type, and location of …